BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mendes LS, Nita ME, Ono-Nita SK, Mello ES, Silva LCD, Alves VA, Carrilho FJ. Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients. World J Gastroenterol 2008; 14(16): 2522-2528 [PMID: 18442199 DOI: 10.3748/wjg.14.2522]
URL: https://www.wjgnet.com/1948-5182/full/v14/i16/2522.htm
Number Citing Articles
1
Omar A. Saldarriaga, Bradley Dye, Judy Pham, Timothy G. Wanninger, Daniel Millian, Michael Kueht, Benjamin Freiberg, Netanya Utay, Heather L. Stevenson. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcomeScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93881-7
2
Waqar Ahmad, Bushra Ijaz, Fouzia T Javed, Sana Gull, Humera Kausar, Muhammad T Sarwar, Sultan Asad, Imran Shahid, Aleena Sumrin, Saba Khaliq, Shah Jahan, Asim Pervaiz, Sajida Hassan. A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)BMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-44
3
Tomohiro Takamura, Utaroh Motosugi, Shintaro Ichikawa, Katsuhiro Sano, Hiroyuki Morisaka, Tomoaki Ichikawa, Nobuyuki Enomoto, Hiroshi Onishi. Usefulness of MR elastography for detecting clinical progression of cirrhosis from child‐pugh class A to B in patients with type C viral hepatitisJournal of Magnetic Resonance Imaging 2016; 44(3): 715 doi: 10.1002/jmri.25182
4
Muhammad Shahid, Muhammad Idrees, Bilal Nasir, Arsalan J. Raja, Syed M. Raza, Iram Amin, Afza Rasul, Ghias U. Tayyab. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patientsEuropean Journal of Gastroenterology & Hepatology 2014; 26(7): 788 doi: 10.1097/MEG.0000000000000109